Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12617000922370
ACTRN12617000922370
Recruiting
Phase 1

nderstanding the Inflammatory mechanisms and effect of Colchicine in patients with End stage renal failure undergoing Dialysis

A/Prof Sanjay Patel0 sites100 target enrollmentJune 26, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Kidney DiseaseHaemodialysisInflammationRenal and Urogenital - Kidney diseaseInflammatory and Immune System - Other inflammatory or immune system disorders

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Chronic Kidney Disease
Sponsor
A/Prof Sanjay Patel
Enrollment
100
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2017
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A/Prof Sanjay Patel

Eligibility Criteria

Inclusion Criteria

  • •Patients with end stage renal failure on haemodialysis

Exclusion Criteria

  • •Known hypersensitivity to colchicine
  • •Moderate hepatic dysfunction (Alanine Aminotransferase 1\.5x upper limit of normal range)
  • •Thrombocytopaenia or leukopaenia
  • •Pregnant or lactating women and women at risk of pregnancy
  • •Patients taking moderate\-strong CYP3A4 inhibitors
  • •Patients already taking Colchicine
  • •Those with evidence of active infection of inflammatory conditions that might be associated with markedly elevated CRP levels in the blood and those taking other anti\-inflammatory therapies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Towards understanding the interplay of inflammation, immunity and circulating cells in atherosclerosis development in young adulthood: a magnetic resonance study10003216induration of the arteriesarteriosclerosishardening of the arteries
NL-OMON40481niversitair Medisch Centrum Utrecht520
Recruiting
Not Applicable
The role of local and systemic inflammation in inflammatory bowel disease, autoimmune disease, and cardiometabolic disease.K52I10E11G35Other noninfective gastroenteritis and colitisEssential (primary) hypertensionType 2 diabetes mellitusMultiple sclerosis
DRKS00031203Charité - Universitätsmedizin Berlin300
Not yet recruiting
Not Applicable
The role of inflammatory factors in the pathogenesis of osteoporosisosteoporosisweakening bone disorder1000381610005959
NL-OMON29779Vrije Universiteit Medisch Centrum30
Completed
Not Applicable
Acute and Chronic inflammatory responses induced by smoking in individuals being susceptible and non-susceptible for development of COPD: from specific disease phenotyping towards novel therapy (study 2).chronic obstructive bronchitis (COPD)emphysema10046304
NL-OMON32401niversitair Medisch Centrum Groningen300
Recruiting
Not Applicable
Role of inflammatory cells in the pathophysiology of obstructive pulmonary disease (COPD and bronchial asthma)
JPRN-UMIN000020726Department of Respiratory Medicine, Tohoku University Graduate School of Medicine100